Healthcare DIVE October 24, 2024
Caroline Colvin

GLP-1 coverage needs to be holistic to ensure long-term success, experts said.

The Ozempic zeitgeist has trickled from doctor’s waiting rooms and pop culture forums into the virtual break room. If employees are asking about GLP-1 coverage — in pursuit of general weight loss, not just to treat diabetes — HR may need a plan.

At a recent Digital Health New York session titled “The Economics of Obesity: Making Coverage Work,” various health experts addressed what HR needs to know about these niche benefits.

The question of cost

Elina Onitskansky, CEO of Ilant Health, raised the question of financial viability, for workers, sponsors and the healthcare system as a whole.

“How do you make sure you are capturing value?”...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Employer, Patient / Consumer, Pharma / Biotech
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Advocate Health takes to Capitol Hill on hospital at home: 5 notes

Share This Article